drugset
drugset / Trial / NCT04553042

A Study of Seltorexant in Healthy Participants

NCT04553042 ↗

Phase 1 Completed 69 enrolled Janssen Research & Development, LLC
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to evaluate the bioequivalence of Test 1 and/or Test 2 seltorexant tablet formulations with respect to Reference seltorexant tablet formulation in healthy participants receiving a single dose under fasted conditions.

Timeline

Start
2020-09-14
Primary completion
2020-12-20
Completion
2020-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Seltorexant Small molecule — Oral

Indications

No indication recorded.